Candidate takes novel approach to targeting DNA damage response
BMS and Nektar’s combination latest in frenzied immunotherapy field
Chief executive Steve Harris confident company can bounce back
But reprieve may last only until plans have been reviewed.
Innovative event aims to improve clinical trials awareness and recruitment.
Can medical-grade wearables provide efficient, patient-friendly, and cost-effective solutions in an ever-changing healthcare environment?
Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.